One study reveals that in a prophylactic tumor vaccination model using PDT-treated TC1 lung cancer cells, redaporfin acts as an ICD inducer that can trigger eIF2a phosphorylation, DAMPs release and inhibit tumor growth (193). Here, EIF2A is linked to neoplasm.